Once a drug successfully moves through clinical trials, regulatory bodies review the data to assess the drug’s clinical efficacy against the disease and whether it is well tolerated in humans. 8 A ...

Lynn Jagodzinski CTSI Clinical Research Regulatory Administrator (716) 888-4843 [email protected] Urmo Jaanimägi CTSI Quality Assurance Specialist (716) 888-4760 [email protected] Here is where ...

Europe conference, which took place between 29 and 30 April in Barcelona, Spain, industry experts delivered comprehensive insights, examined emerging trends and tackled regulatory and operational ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

Zheng Su discusses the key challenges in clinical trials across the Western and emerging regions, specifically looking at patient recruitment and clinical research. The past decades have witnessed ...

As regulatory frameworks continue to evolve, ECAs should become an increasingly accepted component of clinical research. Best Practices For Designing External Control Arms ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments Provided by GlobeNewswire May 14, 2025, 9:00:00 AM ...